BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Makenga Bof JC, Muteba D, Mansiangi P, Ilunga-Ilunga F, Coppieters Y. Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo. BMC Pharmacol Toxicol 2019;20:49. [PMID: 31420005 DOI: 10.1186/s40360-019-0327-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hoang R, Temple C, Correia MS, Clemons J, Hendrickson RG. Characteristics of ivermectin toxicity in patients taking veterinary and human formulations for the prevention and treatment of COVID-19. Clin Toxicol (Phila) 2022;60:1350-5. [PMID: 36374218 DOI: 10.1080/15563650.2022.2134788] [Reference Citation Analysis]
2 Sumo L, Ntonifor NH, Afor AR, Bopda J, Bamou Heumou R, Ondoua Nganjou GS, Nana Djeunga HC. Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination. Acta Trop 2022;225:106218. [PMID: 34755644 DOI: 10.1016/j.actatropica.2021.106218] [Reference Citation Analysis]
3 El Ridi R. Anti-Parasite Agents and Vaccines. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00096-3] [Reference Citation Analysis]
4 Singh L, Singh K. Ivermectin: A Promising Therapeutic for Fighting Malaria. Current Status and Perspective. J Med Chem 2021;64:9711-31. [PMID: 34242031 DOI: 10.1021/acs.jmedchem.1c00498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Onakpoya IJ. Antihelminthic drugs. Side Effects of Drugs Annual 2020. [DOI: 10.1016/bs.seda.2020.08.003] [Reference Citation Analysis]